See also this year's filing and all EDGAR filings for this company.
PDF Report 0001597553_2019_Sage_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001597553, Sage Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 944,695,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 5,643,000 |
| 3 | remainder_Assets | 2,367,000 |
| 4 | LiabilitiesCurrent | 86,030,000 |
| 5 | LiabilitiesNoncurrent | 3,704,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 201,404,000 |
| 9 | ResearchAndDevelopmentExpense | 282,107,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 90,273,000 |
| 12 | remainder_NetIncome | 20,356,000 |
| 13 | remainder_ComprehensiveNetIncome | -486,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 952,705,000 |
| 1 | Liabilities | 89,734,000 |
| 2 | Expenses | 483,511,000 |
| 3 | Revenues | 90,273,000 |
| 4 | StockholdersEquity | 862,971,000 |
| 5 | NetIncome | -372,882,000 |
| 6 | ComprehensiveNetIncome | -373,125,000 |
| 7 | BaseVar | 818,532,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.89 |
| 9 | EconomicCapitalRatio | 3.62 |